Al-Humadi Hussam W, Al-Saigh Rafal J, Al-Humadi Ahmed W
Department of Pharmacology and Toxicology, Pharmacy College, University of Babylon, Babylon, Iraq.
Laboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Front Pharmacol. 2017 Sep 26;8:689. doi: 10.3389/fphar.2017.00689. eCollection 2017.
Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000).
结核病(TB)是一种极具传染性的疾病,仍然对人类健康构成威胁。导致结核病的病原体结核分枝杆菌(MTB)采用多种方式在各种宿主病变中存活,并随后逃避免疫监视;因此,抗击结核病及其相关的多重耐药性一直是一项持续的挑战。这篇综述文章的目的是总结在抗击结核病中药物研发和使用的历史顺序,特别强调第二次世界大战至21世纪初(2000年)这几十年。